Type 2 Diabetes: cohort study finds that compared with other antidiabetic drugs, sitagliptin and saxagliptin do not increase the risk of heart failure (May-16)

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Updated NICE guidance on Type-2 Diabetes – recommendations on drug treatments (Jan-16)

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

NPC Archive Item: Insulin analogues cost NHS millions

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 24 October 2011 A UK study found that if all analogue insulin dispensed in the UK between 2000 and 2009 had been for human insulin alternatives, the NHS would […]